Because an improved prognosis of patients with MM is associated with higher numbers of tumor-infiltrating lymphocytes (TILs), especially CD8+ T cells, we also compared the profiles of the different cell types (effector T lymphocytes, regulatory T lymphocytes [Treg], macrophages, dendritic cells, and natural killer cells) in the TILs in the different treated groups. This evidence concerns the gene CD8A and Miyoshi myopathy.